These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 26593443)
1. AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription. Okuda H; Kanai A; Ito S; Matsui H; Yokoyama A Nat Commun; 2015 Nov; 6():8869. PubMed ID: 26593443 [TBL] [Abstract][Full Text] [Related]
2. RNA Polymerase II-Dependent Transcription Initiated by Selectivity Factor 1: A Central Mechanism Used by MLL Fusion Proteins in Leukemic Transformation. Yokoyama A Front Genet; 2018; 9():722. PubMed ID: 30693017 [TBL] [Abstract][Full Text] [Related]
3. TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription. Okuda H; Takahashi S; Takaori-Kondo A; Yokoyama A Cell Cycle; 2016 Oct; 15(20):2712-22. PubMed ID: 27564129 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation by MLL fusion proteins in leukemogenesis. Yokoyama A Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805 [TBL] [Abstract][Full Text] [Related]
6. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3. Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759 [TBL] [Abstract][Full Text] [Related]
7. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Yokoyama A; Lin M; Naresh A; Kitabayashi I; Cleary ML Cancer Cell; 2010 Feb; 17(2):198-212. PubMed ID: 20153263 [TBL] [Abstract][Full Text] [Related]
8. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system. Yokoyama A Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718 [TBL] [Abstract][Full Text] [Related]
9. Estradiol induces gene proximity and MLL-MLLT3 fusion in an activation-induced cytidine deaminase-mediated pathway. Wright RL; Slemmons KK; Vaughan AT Leuk Lymphoma; 2015 May; 56(5):1460-5. PubMed ID: 25130479 [TBL] [Abstract][Full Text] [Related]
15. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment. Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328 [TBL] [Abstract][Full Text] [Related]
16. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074 [TBL] [Abstract][Full Text] [Related]
17. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4. Bursen A; Schwabe K; Rüster B; Henschler R; Ruthardt M; Dingermann T; Marschalek R Blood; 2010 Apr; 115(17):3570-9. PubMed ID: 20194896 [TBL] [Abstract][Full Text] [Related]
18. The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures. Benedikt A; Baltruschat S; Scholz B; Bursen A; Arrey TN; Meyer B; Varagnolo L; Müller AM; Karas M; Dingermann T; Marschalek R Leukemia; 2011 Jan; 25(1):135-44. PubMed ID: 21030982 [TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia. Bizarro S; Cerveira N; Correia C; Lisboa S; Peixoto A; Norton L; Teixeira MR Cancer Genet Cytogenet; 2007 Oct; 178(1):61-4. PubMed ID: 17889710 [TBL] [Abstract][Full Text] [Related]
20. Keeping RNA polymerase II on the run: Functions of MLL fusion partners in transcriptional regulation. Basu S; Nandy A; Biswas D Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194563. PubMed ID: 32348849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]